GL1X · GenesisL1 explorer

MolNFT v1 · #14122 · protein

Structural and functional analyses of the arg-gly-asp sequence introduced into human lysozyme

1LZ6: “Structural and functional analyses of the arg-gly-asp sequence introduced into human lysozyme”. X-ray diffraction, 1 ligand (CL), 1 pocket (best druggability 0.35). MolNFT v1 #14122 on GenesisL1: 3D structure, binding sites and…

PDB
1LZ6
Type
protein
Length
138 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human lysozyme
EC
3.2.1.17
UniProt
P61626
Ligands
CL
Pockets
1 · best druggability 0.35

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHuman lysozyme (EC 3.2.1.17)protein13837% helix, 12% strandP61626

Ligands and binding sites

  • CL · Chloride ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1850.350.7514empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1LZ6 · Structural and functional analyses of the arg-gly-asp sequence introduced into human… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.